TSLP (Thymic Stromal Lymphopoietin) is a pleiotropic cytokine primarily secreted by epithelial cells, fibroblasts, mast cells, etc. It mainly acts on various cells such as dendritic cells, T cells, and B cells, promoting their activation, differentiation, and proliferation, and inducing them to secrete Th2 cytokines. It activates signaling...
TSLP (Thymic Stromal Lymphopoietin) is a pleiotropic cytokine primarily secreted by epithelial cells, fibroblasts, mast cells, etc. It mainly acts on various cells such as dendritic cells, T cells, and B cells, promoting their activation, differentiation, and proliferation, and inducing them to secrete Th2 cytokines. It activates signaling pathways like JAK-STAT, thereby initiating Th2-type immune responses and playing a crucial role in immune regulation, inflammatory responses, and disease development.
CD5 (Cluster of Differentiation 5) is a key transmembrane glycoprotein receptor belonging to the scavenger receptor family. Its core function is to negatively regulate signaling mediated by the T-cell receptor (TCR) and B-cell receptor (BCR), thereby maintaining immune tolerance in the body and preventing excessive lymphocyte activation. For...
CD5 (Cluster of Differentiation 5) is a key transmembrane glycoprotein receptor belonging to the scavenger receptor family. Its core function is to negatively regulate signaling mediated by the T-cell receptor (TCR) and B-cell receptor (BCR), thereby maintaining immune tolerance in the body and preventing excessive lymphocyte activation. For instance, within tumor cells, CD5 promotes proliferation, survival, and inhibits apoptosis by regulating pathways such as NF-κB and PI3K/Akt. CD5 is a classic marker for T cells and is expressed on the surface of nearly all mature T cells. Additionally, it is expressed on subsets of B cells and NK cells but is not expressed on normal hematopoietic stem cells or non-hematopoietic solid tissues. This highly restricted expression profile provides an ideal foundation for developing highly specific, low off-target toxicity targeted therapies.